Identification and validation of cholesterol homeostasis and NK cell-associated predictive and therapeutic models for Coronary atherosclerotic heart disease patients with ST-elevated myocardial infarction: Insights from artificial intelligence and multi-omics

Comput Biol Chem. 2026 May 14;124(Pt 1):109103. doi: 10.1016/j.compbiolchem.2026.109103. Online ahead of print.ABSTRACTOBJECTIVE: Dysregulation of Cholesterol homeostasis(CH) and NK cells proportion can increase risk of ST-Elevated Myocardial Infarction(STEMI) for Coronary atherosclerotic heart dise

X Xuemei Chen

Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0-3: evidence from CHARLS 2011-2020

Cardiovasc Diabetol. 2026 May 16. doi: 10.1186/s12933-026-03206-z. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3 represent a critical window for preventing progression to overt cardiovascular disease (CVD). Insulin resistance (IR) is central to C

S Shu-Shu Han

Coronary Artery Disease in Masters Athletes: A Systematic Review

Sports Med. 2026 May 16. doi: 10.1007/s40279-026-02429-0. Online ahead of print.ABSTRACTBACKGROUND: Despite undertaking large volumes of structured exercise training, evidence suggests that masters athletes (MAs) remain susceptible to coronary artery disease (CAD). This review evaluated the prevalen

S Shaqira Gill